PMID- 12625413 OWN - NLM STAT- MEDLINE DCOM- 20030924 LR - 20190906 IS - 0918-8959 (Print) IS - 0918-8959 (Linking) VI - 49 IP - 6 DP - 2002 Dec TI - Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1. PG - 635-40 AB - Two juvenile patients with multiple endocrine neoplasia type 1 (MEN1) who developed pituitary adenomas are reported. The first case, a 14-year-old girl, developed prolactinoma and manifested delayed puberty and growth arrest. The second case, a 16-year-old boy, was asymptomatic and a pituitary adenoma accompanied by mild elevation of PRL and GH was identified through family screening. His growth and pubertal development was not impaired. Medication with bromocriptine was started for both cases with good therapeutic responses. These cases emphasize relevance of early screening of endocrine disorders for members of families with MEN1. FAU - Oiwa, Ako AU - Oiwa A AD - Department of Aging Medicine and Geriatrics, Shinshu University School of Medicine, Matsumoto 390-8621, Japan. FAU - Sakurai, Akihiro AU - Sakurai A FAU - Sato, Yoshihiko AU - Sato Y FAU - Sakuma, Takahiro AU - Sakuma T FAU - Yamashita, Koh AU - Yamashita K FAU - Katai, Miyuki AU - Katai M FAU - Aizawa, Toru AU - Aizawa T FAU - Hashizume, Kiyoshi AU - Hashizume K LA - eng PT - Case Reports PT - Journal Article PL - Japan TA - Endocr J JT - Endocrine journal JID - 9313485 RN - 0 (Hormone Antagonists) RN - 3A64E3G5ZO (Bromocriptine) SB - IM MH - Adolescent MH - Bromocriptine/therapeutic use MH - Female MH - Hormone Antagonists/therapeutic use MH - Humans MH - Male MH - Multiple Endocrine Neoplasia Type 1/diagnosis/drug therapy/*genetics MH - Pedigree MH - Pituitary Neoplasms/*diagnosis/drug therapy/*genetics MH - Prolactinoma/*diagnosis/drug therapy/*genetics EDAT- 2003/03/11 04:00 MHDA- 2003/09/25 05:00 CRDT- 2003/03/11 04:00 PHST- 2003/03/11 04:00 [pubmed] PHST- 2003/09/25 05:00 [medline] PHST- 2003/03/11 04:00 [entrez] AID - 10.1507/endocrj.49.635 [doi] PST - ppublish SO - Endocr J. 2002 Dec;49(6):635-40. doi: 10.1507/endocrj.49.635.